CDMO & API, formulations, CRO & clinical, consulting & services, biologics & research tools and more: the companies building biopharma outsourcing in Tamil Nadu, with their founders, funding, team size and business models.
Recent biopharma outsourcing business events in India
Funding, M&A, contract wins and launches involving 2,490 biopharma outsourcing companies in India, last 24 months: 81 M&A deals · 18 Contracts · 18 funding rounds · 3 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.
The Indian government has officially approved the acquisition of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL) by Skymap Pharmaceuticals Pvt Ltd for ₹121 crore.
Indoco Remedies has successfully completed the transfer of its ophthalmic business division to Sunways (India) Private Limited. This strategic move, finalised on May 18, 2026, involves…
DataM Intelligence has unveiled its latest report on the 'Synchronous Motors Market Size 2026' delivering powerful insights into key trends, future growth opportunities, and evolving…
Report
ContractSupply
Panacea biotec · client: Central Medical Services Society (CMSS)
Panacea Biotec has announced the receipt of a Letter of Award from the Central Medical Services Society (CMSS), under the Ministry of Health and Family Welfare, Government of India. The…
Jubilant Ingrevia has successfully acquired a 100% equity stake in Remidex Pharma Private Limited.
Pharmaceutical
M&AMerger · Announced
EPL acquires Indovida India Private Limited
EPL Limited and Indovida India Private Limited have today signed definitive agreements for a merger. The combined platform will have a valuation of ~$2 billion.
SteinCares, a specialty healthcare company in Latin America, entered into a strategic licensing agreement with Shilpa Biologicals Pvt. Ltd.
Healthcare
M&AAcquisition · Rumored
Consortium led by Warburg Pincus and Mubadala acquires Encube ethicals
Separately, a consortium led by Warburg Pincus and Abu Dhabi-based sovereign investor Mubadala is in advanced talks to buy a majority stake in contract manufacturer Encube Ethicals, ET…
Separately, a consortium led by Warburg Pincus and Abu Dhabi-based sovereign investor Mubadala is in advanced talks to buy a majority stake in contract manufacturer Encube Ethicals
New Delhi: Eris Lifesciences Limited has completed the acquisition of the remaining 30 percent stake in Swiss Parenterals Limited, making it a wholly owned subsidiary
Two Jubilant Bhartia Group subsidiaries raised a combined 56.50 billion rupees through zero-coupon bonds in June to fund the acquisition of a 40% stake in Hindustan Coca-Cola Holdings.
Aurobindo Pharma, a wholly owned subsidiary of Aurobindo Pharma, at its meeting held on Monday, i.e., January 1, 2026, has approved the acquisition of the non-oncology prescription…
Pharmaceuticals
M&AAcquisition · Completed
Cactus acquires Baker Hughes Company’s Surface Pressure Control business
Cactus, Inc. today announced the completion of the acquisition of a majority interest in Baker Hughes Company’s Surface Pressure Control business.
Aurobindo Pharma Ltd said its wholly owned arm, Auro Pharma Ltd, has acquired the branded non-oncology prescription formulations business of Khandelwal Laboratories Private Ltd on a…
Piramal Pharma Limited (PPL) has entered into an agreement to acquire a 100% stake in Hemmo Pharmaceuticals Pvt. Ltd., an Indian manufacturer of synthetic peptide APIs (active…
Earlier in October, UNICEF also placed a significant order for polio vaccines. Panacea Biotec received the letter of award (LoA) as part of a long-term agreement to supply bOPV in 10 and…
Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor to Eris Lifesciences Limited (“ELL”) in connection with its proposed acquisition of 30% of the total share capital of…
The National Company Law Tribunal (NCLT) has approved the merger of SeQuent Scientific, a leading player in the global animal health industry, and Viyash Lifesciences, an integrated…
ANG Lifesciences India, a fast-growing organisation with an ultra-modern fully integrated, manufacturing facility dedicated to dry powder injectables (SVP), has acquired the printing and…
Global private equity firms Advent International and Warburg Pincus have joined the race for a stake purchase in contract drug maker Encube Ethicals Pvt. Ltd.
Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor for an on-market sale of 8.93% shareholding in Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited)…
SAM has earlier advised Advent in its control acquisition of Suven Pharmaceuticals Limited by way of a share purchase and mandatory open offer.
Biopharma outsourcing companies in Tamil Nadu, by revenue
Browse biopharma outsourcing companies in Tamil Nadu by reported revenue, one-year revenue growth, revenue model, age and stage. The 50 companies below are the largest by their most recent reported revenue among 67 biopharma outsourcing companies in Tamil Nadu that have filed a figure in the last four years. Every figure keeps its own reporting period, so compare periods before comparing amounts.
Showing 25 of 50
Company & businessRevenueRevenue growthHeadcount & growthAgeJobs · last 3 months
Provider of clinical data management services to biopharma sector
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Contract pharmaceutical manufacturing company specializing in the production of liquid injections and pre-filled syringes, offering a range of filtration products and services
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Pharmaceutical distribution company that sources and supplies active pharmaceutical ingredients, nutraceuticals, intermediates, excipients, herbal extracts, and packing materials
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Pharmaceutical manufacturing company produces a range of generic medications, including tablets, capsules, and syrups, for various therapeutic categories
Every company, not just 50All 119 biopharma outsourcing companies in Tamil Nadu, filterable by stage, funding, team size, revenue model and age.
Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
Save and exportBuild lists, compare companies side by side and export them from your Radar account.
Explore biopharma outsourcing companies in Tamil Nadu by what you are looking for
Browse biopharma outsourcing companies in Tamil Nadu by service, from CDMO and API manufacturing to clinical research. You can also see listed biopharma companies, biopharma startups in Tamil Nadu and companies that are hiring.
8 ways to explore biopharma outsourcing in Tamil Nadu
CDMO & API manufacturing companiesFormulation & finished dosage manufacturersContract research (CRO) & clinical development companiesPharma consulting & functional service providersBiologics, drug discovery & life science tools companiesListed biopharma outsourcing companies in Tamil Nadu
CDMO & API manufacturing companies
Contract development and manufacturing of APIs, intermediates and small molecules.
Steril-Gene
Pharmaceutical company manufacturing a range of pharmaceutical preparations
Revenue, profit and growth from the filed annual accounts of 63 biopharma outsourcing companies in Tamil Nadu for FY24-25 — 72 of the 119 companies on this page file accounts with the Ministry of Corporate Affairs. The five largest earn 62% of the revenue, so medians describe the typical company better than totals.
combined revenue, FY24-25₹3,312.69 cr
63 companies filing accounts
combined net profit₹351.10 cr
10.6% aggregate margin
are profitable78%
49 of 63 companies
median revenue~₹15.8 cr
the typical company
median revenue growth+4%
into FY24-25
earned by the top five62%
revenue concentration
Six-year view
Combined revenue of filing companies
₹1,640.92 crFY19-2055 filers
₹1,858.19 crFY20-2158 filers
₹3,248.21 crFY21-2263 filers
₹2,978.87 crFY22-2366 filers
₹3,337.79 crFY23-2467 filers
₹3,312.69 crFY24-2563 filers
The number of companies filing changes each year; the three-year cohort below compares like with like.
Like-for-like
The same 59 companies over three years
+28%
FY22-23₹2,507.31 cr₹246.86 cr net
FY23-24₹2,841.45 cr₹348.12 cr net
FY24-25₹3,198.25 cr₹426.90 cr net
Companies with accounts for all three years, so growth is not an artefact of who filed.
Scale and profit
Bigger companies are far more often profitable
Under ₹1 cr1443% profitable
₹1–10 cr1080% profitable
₹10–100 cr3388% profitable
₹100–1,000 cr6100% profitable
Over ₹1,000 cr0—
Companies by FY24-25 revenue. Bars show how many companies sit in each band.
Momentum
How fast revenue moved into FY24-25
Shrinking28
0–20%17
20–50%8
50–100%3
Doubled+5
61 companies with accounts for both years; median growth +4%.
Profitability
Profit is concentrated at the top
49profitable
14loss-making
10.6%aggregate margin
2.5%median margin
The aggregate margin is pulled up by a few large filers; the median shows the typical company.
Growth leaders · ₹10 cr+ revenue
Fastest growing, FY24-25
Company
Growth
Revenue
AxxelentAXXELENT PHARMA SCIENCE PRIVATE LIMITED
+237%
₹64.29 cr
SVISS LABSSSVISS LABSS PRIVATE LIMITED
+58%
Steril-GeneSTERIL-GENE LIFE SCIENCES PRIVATE LIMITED
Standalone annual accounts filed with the Ministry of Corporate Affairs. Brands that share one legal entity are shown together and counted once.
For investors and data teams
Put this intelligence into your own tools
The figures on this page come from Fliar’s company, funding and MCA filings data. Use it through the Investor Intelligence API and MCA financials feeds, or explore every company, filing and investor in Radar.
Capital & corporate activity
Biopharma outsourcing funding and M&A across India
193 recorded equity rounds have gone to 2,490 biopharma outsourcing companies in India — how much, at which stage, into which sub-sectors, from whom, and how Tamil Nadu compares. Debt, IPO and grant rounds are excluded.
equity rounds, last 12 months2
US$270.00m
equity rounds, last 24 months7
US$425.09m
raised over five yearsUS$1.28bn
51 rounds in India
M&A deals, India81
last 24 months
Capital by year
Equity funding into biopharma outsourcing in India
amount rounds
$84m201811
$134m20199
$62m202011
$435m202116
$315m202214
$90m20238
$19m20246
$155m20256
$270m20261
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$435.16m across 16 rounds.
The funding ladder · five years
Rounds and typical cheque by stage
AngelUS$119.62m12 rounds · median US$500k
SeedUS$14.38m11 rounds · median US$1.29m
Series AUS$80.53m9 rounds · median US$4.40m
Series BUS$106.78m7 rounds · median US$16.27m
Series CUS$255.00m3 rounds · median US$80.00m
Series D+US$284.18m2 rounds · median US$142.09m
Private equityUS$423.40m7 rounds · median US$68.00m
Medical research labsUS$500k1 rounds · 1 companies
Food safety testingUS$0k1 rounds · 1 companies
Tamil Nadu in context
Tamil Nadu’s share of India’s biopharma outsourcing funding
Rounds4%2 of 51
Capital20%US$250.77m of US$1.28bn
Equity rounds over the last five years, 129 biopharma outsourcing companies in Tamil Nadu among 2,490 in India.
Corporate activity · last 24 months
M&A in India
67Acquisition
14Merger
Most active acquirers
Jubilant bhartia group6
Sequent scientific5
Optimus4
Eris lifesciences3
Cactus3
Most acquired or merged
Schott poonawalla7
Encube ethicals4
OTRS AG4
SWISS PARENTERALS3
Gland pharma3
Each deal appears in the events strip at the top of the page.
Founders and momentum in Tamil Nadu
Meet the people behind biopharma outsourcing companies in Tamil Nadu. 50 of 119 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Fastest revenue growth
Biopharma outsourcing companies in Tamil Nadu with the highest one-year revenue growth among those reporting at least ₹5 crore in revenue. Growth is the reported one-year change for the period shown.
Biopharma outsourcing
Contract research, development, and manufacturing organization providing end-to-end services for the pharmaceutical industry
Revenue growth · 2024–2025Revenue · FY 2024-25
Founders
Details not available
Biopharma outsourcing
CDMO focused on manufacturing pharmaceutical formulations and regulatory support services
Provider of life sciences and supply chain management services
Revenue growth · 2024–2025Revenue · FY 2024-25
Leadership · 1
RY
Ram YeleswarapuCEO & President
Biopharma outsourcing
Pharmaceutical manufacturing company produces a range of generic medications, including tablets, capsules, and syrups, for various therapeutic categories
Revenue growth · 2024–2025Revenue · FY 2024-25
Founders
Details not available
Biopharma outsourcing
Pharmaceutical company manufacturing a range of pharmaceutical preparations
Contract pharmaceutical manufacturing company specializing in the production of liquid injections and pre-filled syringes, offering a range of filtration products and services
Focus: Pharmaceutical solid-form development and synthesis processes for small‑molecule APIs
CPC C07D295/088, A61K9/1617, C07D405/06
Technology
PHP
MySQL
WordPress
jQuery
Detected on the company website
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Women-founded
Biopharma outsourcing companies in Tamil Nadu with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
Biopharma outsourcing
Provider of healthcare market research and decision-support for global firms
We will reply with coverage, fields and pricing for your use case.
Radar members
Log in to see every figure
Filed revenue, profit and growth for every company on this page are available with a Radar account. Log in and you will come straight back here with all figures open.